Protective effects of epigallocatechin gallate (EGCG) derivatives on azoxymethane-induced colonic carcinogenesis in mice

Journal of Functional Foods

Volumn 4, Issue 1, 2012, Pages 323-330

  Zhong, Ying ^a   Chiou, Yi Siou ^b   Pan, Min Hsiung ^b   Ho, Chi Tang ^c   Shahidi, Fereidoon ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Aberrant crypt foci (ACF); Colon cancer; COX 2; EGCG ester; INOS

Indexed keywords

MUS;

EID: 84857690392     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2011.12.011     Document Type: Article

References (35)

1. Augenlicht L.H., Richards C., Corner G., Pretlow T.P. Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene 1996, 12:1767-1772.
2. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Letters 1987, 37:147-151.
3. Bouwens M., Van de Rest O., Dellschaft N., Grootte Bromhaar M., de Groot L.C.P.G.M., Geleijnse J.M., Mueller M., Afman L.A. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. American Journal of Clinical Nutrition 2009, 90:415-424.
4. Carter O., Dashwood R.H., Wang R., Dashwood W.M., Orner G.A., Fischer K.A., Lohr C.V., Pereira C.B., Bailey G.S., Williams D.E. Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts. Nutrition and Cancer 2007, 58:60-65.
5. Cheng L., Lai M.D. Aberrant crypt foci as microscopic precursors of colorectal cancer. World Journal of Gastroenterology 2003, 9:2642-2649.
6. Davies M.J., Rumsby P.C. Long-term analysis of colonic aberrant crypt formation after treatment of Sprague-Dawley rats with azoxymethane. Teratogenesis, Carcinogenesis and Mutagenesis 1998, 18:183-197.
7. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van de Putte L.B., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB Journal 1998, 12:1063-1073.
8. Femia A.P. Frequent mutation of Apc gene in rat colon tumours and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Research 2007, 67:445-449.
9. Geng M., Adler G., Gress T. Identification of TGFβ target genes in pancreatic cancer cells by cDNA representational difference analysis. Gastroenterology 1998, 114:A600.
10. Johnson I.T. Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa. Food and Chemical Toxicology 2002, 40:1171-1178.
11. Kundu K.J., Na H.K., Chun K.S., Kim Y.K., Lee S.J., Lee S.S., Lee O.S., Sim Y.C., Surh Y.J. Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. Journal of Nutrition 2003, 133:3805S-3810S.
12. Lin Y.L., Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Molecular Pharmacology 1997, 52:465-472.
13. Magnuson B.A., Carr I., Bird R.P. Ability of aberrant crypt foci characteristics to predict colonic tumour incidence in rats fed cholic acid. Cancer Research 1993, 53:4499-4504.
14. McLellan E.A., Medline A., Bird R.P. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: Putative preneoplastic lesions. Cancer Research 1991, 51:5270-5274.
15. Nomoto H., Iigo M., Hamada H., Kojima S., Tsuda H. Chemoprevention of colorectal cancer by grape seed proanthocyanidin is accompanied by a decrease in proliferation and increase in apoptosis. Nutrition and Cancer 2004, 49:81-88.
16. Paulsen J.E., Løberg E.M., Ølstørn H.B., Knutsen H., Steffensen I.L., Alexander J. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat. Cancer Research 2005, 65:121-129.
17. Pham-Huy L.A.N., He H., Pham-Huy C. Green tea and health: An overview. Journal of Food Agriculture and Environment 2008, 6:6-13.
18. Raju J. Azoxymethane-induced rat aberrant crypt foci: Relevance in studying chemoprevention of colon cancer. World Journal of Gastroenterology 2008, 14:6632-6635.
19. Rodrigues M.A.M., Silva L.A.G., Salvadori D.M.F., de Camargo J.L.V., Montenegro M.R. Aberrant crypt foci and colon cancer: Comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Brazilian Journal of Medical and Biological Research 2002, 35:351-355.
20. Salimath B.P., Arshiya T., Anupama E.G., Bindumalini, Preeti G.B., Salimath P.V. Molecular mechanism of action of butyric acid in Ehrlich ascites tumour cells. Nutrition Research 1999, 19:589-600.
21. Saw C.L.L., Huang Y., Kong A.N. Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: Docosahexaenoic acid or eicosapentaenoic acid. Biochemical Pharmacology 2010, 79:421-430.
22. Shimizu M., Shirakami Y., Sakai H., Adachi S., Hata K., Hirose Y., Tsurumi H., Tanaka T., Moriwaki H. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prevention Research 2008, 1:298-304.
23. Stevens R.G., Swede H., Rosenberg D.W. Epidemiology of colonic aberrant crypt foci: Review and analysis of existing studies. Cancer Letters 2007, 252:171-183.
24. Suganuma M., Ohkura Y., Okabe S., Fujiki H. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumour formation in Min mice. Journal of Cancer Research and Clinical Oncology 2001, 127:69-72.
25. Surh Y.J. NF-κB and AP-1 as molecular targets for chemoprevention with EGCG, a review. Environmental Chemistry Letters 2006, 4:137-141.
26. Takahashi M., Minamoto T., Yamashita N., Kato T., Yazawa K., Esumi H. Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Letters 1994, 83:177-184.
27. Takayama T., Katsuki S., Takahashi Y., Ohi M., Nojiri S., Sakamaki S., Kato J., Kogawa K., Miyake H., Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. New England Journal of Medicine 1998, 339:1277-1284.
28. Takayama T., Ohi M., Hayashi T., Miyanishi K., Nobuoka A., Nakajima T., Satoh T., Takimoto R., Kato J., Sakamaki S., Niitsu Y. Analysis of K-ras, APC beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 2001, 121:599-611.
29. Xiao H., Hao X., Simi B., Ju J., Jiang H., Reddy B.S., Yang C.S. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis 2008, 29:113-119.
30. Yang C.S., Ju J., Lu G., Xiao H., Hao X., Sang S., Lambert J.D. Cancer prevention by tea and tea polyphenols. Asia Pacific Journal of Clinical Nutrition 2008, 17(S1):245-248.
31. Yin P., Zhao J., Cheng S., Hara Y., Zhu Q., Liu Z. Experimental studies of the inhibitory effects of green tea catechin on mice large intestinal cancers induced by 1,2-dimethylhydrazine. Cancer Letters 1994, 79:33-38.
32. Yuan J.H., Li Y.Q., Yang X.Y. Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo (4,5-f) quinoline in mice. Molecular Medicine 2008, 14:590-598.
33. Zhong Y., Ma C.M., Shahidi F. Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives. Journal of Functional Foods 2011, 4:87-93.
34. Zhong Y., Shahidi F. Lipophilized epigallocatechin gallate (EGCG) derivatives as novel antioxidants. Journal of Agricultural and Food Chemistry 2011, 59:6526-6533.
35. Zhong Y., Shahidi F. Lipophilized epigallocatechin gallate (EGCG) derivatives and their antioxidant potential in food and biological systems. Food Chemistry 2012, 131:22-30.